ClinicalTrials.gg
CompletedNCT07194499Updated Sep 26, 2025

Knowledge and Attitude Among Healthcare Workers Towards Malaria Vaccine, Sudan 2025.

An observational study in Malaria and Malaria Vaccine, sponsored by Research and Publication office. Completed at 1 site in Sudan. Per ClinicalTrials.gov, last updated 2025-09-26.

Sponsored by Research and Publication office · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
222
Sex
All
01

Study summary

This study assesses Sudanese healthcare workers' knowledge and attitudes toward the malaria vaccine in 2025, considering demographic and professional factors. It examines awareness of malaria prevalence, WHO recommendations, vaccine type, efficacy, and safety, along with confidence in recommending it and its acceptability. The findings will aid in designing interventions to improve vaccine uptake and reduce malaria burden.

Read the detailed description

This study aims to assess the knowledge and attitudes of Sudanese healthcare workers (HCWs) toward the malaria vaccine in 2025. It examines how demographic factors and professional roles influence their understanding and perception. The knowledge assessment includes awareness of malaria prevalence, WHO vaccine recommendations, and vaccine type, efficacy, and safety. The attitude evaluation focuses on confidence in recommending the vaccine and perceptions of its feasibility and acceptance in Sudan. The findings will help design targeted interventions to enhance vaccine uptake and reduce the malaria burden.

02

Conditions studied

  • Malaria
  • Malaria Vaccine

Browse trials for

03

In context

Malaria

1,184 studies on the registry are indexed under Malaria; 79 are open to participants now.

This study's enrollment of 222 is below the median of 582 across 204 observational studies indexed under Malaria.

Browse Malaria studies →

Lead sponsor

Research and Publication office is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Study Population Description:

The study will include healthcare workers (doctors, nurses, pharmacists, and public health staff) from various healthcare facilities in Sudan.

Eligibility criteria

Inclusion criteria:

  • Graduates of healthcare profession fields with at least one year of healthcare practice following graduation.
  • Voluntary agreement and written . exclusion criteria: non medical graduates
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
222 participants (actual)
Patient registry
No

Interventions

  • OtherNo interventions

    No intervention

06

What researchers measure

Primary outcomes

  1. Knowledge regarding malaria vaccine

    Included 11 questions about awareness, malaria and malaria vaccination

    Time frame: Jan - Apr 2025

  2. Attitude regarding malaria vaccine

    5 point likert-scale assessment

    Time frame: Jan - Apr 2025

07

Study locations

1 site
  • Research and Publication Office
    Khartoum, Khartoum State 11111, Sudan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07194499
Lead sponsor
Research and Publication office
Responsible party
Sponsor
First posted
Sep 26, 2025
Start date
Jan 16, 2025
Primary completion
Apr 23, 2025
Completion
Apr 23, 2025
Last update
Sep 26, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion